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Abstract and keywords 
 
 
Abstract 
 
Aim 
Early intervention (EI) in psychosis is a comprehensive and evidence-based approach aimed 
at detection and treatment of psychotic symptoms in their early stages. This paper presents 
core features and noteworthy aspects of the evidence basis and limitations of EI, the 
importance of program fidelity, challenges for its widespread dissemination, and economic 
perspectives related to it.  
 
Methods   
This paper is a narrative review about the evidence supporting EI and the challenges to its 
widespread dissemination.   
 
 
Results  
In spite of evidence of a wide range of benefits, widespread dissemination has been slow, and 
even currently implemented programmes might be threatened. This reflects in part the 
shortcomings of mental healthcare in general, such as low priority for funding, stigma and 
structural problems. Successful examples of advocacy, mobilisation and destigmatisation 
campaigns have overcome these difficulties. 
 
Conclusions 
Funding for mental health in general and for EI services appears low relative to need. One key 
argument for better funding for EI can be found in its favourable cost-effectiveness, but not all 
stakeholders beyond mental health administrators are aware of this. Positive impacts of EI 
programmes on excess unemployment and tax forgone suggest that social affairs and labour 
ministries – and not only health ministries – could be more involved in governance of mental 
health issues; ministries of justice and education are other sector stakeholders than can 
benefit. Wider dissemination of EI services will probably benefit from better integration of 
potential funders, promotion of joint targets and shared financial or budgetary incentives. 
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Introduction 
 
Early intervention (EI) in psychosis is a comprehensive and evidence-based approach aimed 
at detection and treatment of psychotic symptoms in their early stages, in order to reduce the 
long-term adverse impact of psychosis and prevent relapses. It focuses on people with ultra-
high risk for psychosis and those with initial psychotic symptoms; it relies on the concept of 
clinical staging of psychosis – which states that early and milder clinical phenomena differ from 
those that accompany illness extension, progression and chronicity 
1
.  
 
EI programmes have originated out of research showing convincing evidence of association 
between shorter duration of untreated psychosis (DUP) and benefit on relevant outcomes at 
12 months, including positive and negative symptoms, depression, anxiety, overall functioning, 
and social functioning 
2
.  
 
At the core of EI services is the concept of specialized assertive teams, in which staff 
members have a reduced caseload compared to conventional mental health services 
3
. These 
teams are usually multidisciplinary and can include psychiatrists, psychiatric nurses, 
psychologists, social workers, occupational therapists and employment support specialists, 
among others. Clinical management is not restricted to pharmacological intervention, and 
other areas are likewise prioritised, including interpersonal problems, social skills, vocational 
and educational issues, functional recovery, substance abuse, suicidal ideation, and financial 
problems. Family relatives and people close to the patients are generally encouraged to be 
involved in programmes. Teams exert assertive outreach by promoting contact with the patient 
not only at the team offices but also in community settings and patients’ homes, and often 
outside working hours. 
 
Besides this set of characteristic elements, EI services relate to external factors in specific 
ways. They usually have limited catchment areas, where different local agencies such as 
primary and secondary health care professionals, schools and the police are encouraged to 
make direct referrals 
4
. Community awareness and education of local stakeholders in the 
health care system and other services relevant to the mental health of young people are often 
other core elements of EI services 
5
. 
 
Clinically, EI services have shown that it is possible to shorten untreated psychosis, and that 
some positive effects, for instance on employment participation, have persisted for at least 10 
years 
6
. Some of the earliest results have shown that EI services are superior to standard care. 
The Lambeth Early Onset trial, for example, reduced the number of readmissions in 
psychiatric wards as well as dropout rates significantly 
7
. Besides reducing hospitalisation, 
including bed days, and increasing retention in care, EI services have also been shown to 
improve social functioning 
8
 and user satisfaction 
3
.   
 
These robust results were also seen in OPUS, a Danish trial identified as the largest and 
highest quality randomised study by the authors of a systematic review of the scientific 
 5 
 
literature, published in 2011 in the Cochrane Library 
9
. OPUS compared EI with standard care 
and showed positive effects not only on psychotic symptoms, but also on incapacitating 
negative symptoms, such as emotional blunting, lack of drive, inability to experience pleasure, 
and social withdrawal, among others 
10,11
. Significant effects were also seen regarding 
substance abuse and reduced burden of illness experienced by family members 
12
. 
 
The OPUS trial showed not only the benefit of EI and its core elements – it demonstrated also 
an incremental improvement in a health system that already had a good standard of care. The 
existing literature is in line with this. Thus, a Cochrane review that showed the superiority of 
intensive case management for severe mental illness as compared to standard care included 
38 studies – all from developed countries 8. Another systematic review that showed the benefit 
of a reduced DUP included 26 studies with a total of 5000 patients – only 3 (with around 200 
patients) were from developing countries 
2
.  
 
All identified core elements of EI seem to contribute to these positive effects. In Hong Kong, 
enormous efforts to enhance public awareness were undertaken in combination with 
implementation of EI services. During the period from 2000 to 2010, EI was associated with 
decreases of up to two thirds in the duration of untreated psychosis, particularly among 
patients who were expected to benefit from a higher level of awareness in the general 
population (and thus better early detection and referral): patients with gradual onset of 
symptoms, patients without family experience of psychosis, and adult patients, suggesting that 
public awareness actions reduced the duration of untreated psychosis in groups previously 
suffering from the longest delay 
13,14
.  
 
Not only people who already have symptoms benefit from EI programs. Focus on people at 
ultra-high risk has been associated with fewer admissions to hospital, less compulsory 
treatment 
15
, and a reduction of the period of untreated psychosis to 11 days 
16
. 
 
But evidence of the benefit of EI services is not yet conclusive. Beneficial effects on symptoms 
and function seen after two years of specialized and intensive services in the OPUS trial, for 
example, were not sustained after five years (i.e. after three years of standard treatment) 
17
. It 
is unknown whether the desired effects on symptoms and function require on-going EI 
services; or whether a two-year EI program, as it was offered in that particular program, was 
too short. On the other hand, an EI program from Canada suggests that a five-year program 
might have long-lasting effects 
18
. Researchers are actively investigating this question, and 
results from on-going trials are expected to help determine optimal duration of services 
19,20
. It 
is necessary not only to understand the impact of the ingredients of early intervention, but also 
to reappraise the elements of the standard care to which patients are transferred to after EI 
21
. 
This is especially important in developing countries, where constraints in manpower, funding 
and even basic supplies affect standard care 
22
. 
 
Besides, it is important to adequately evaluate standard care in general – both in rich and 
developing countries – and to identify the elements of standard care; otherwise there is a 
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danger that EI programmes will appear more effective than they would otherwise, where 
standard care is poorer than should be the case. 
 
The long-term impact on physical health and mortality due to somatic diseases is also 
unknown. Increased mortality and avoidable ill-health are well known and costly problems 
among people with psychotic disorders 
23,24
, and the impact of EI programmes on these 
outcomes will take years to be clearly measurable. 
 
Another challenge regards EI services for people at ultra-high risk for psychosis. The risk of 
conversion to psychosis versus benefit of preventive approaches and the ratio and 
acceptability of intervention (e.g. antipsychotic vs. psychotherapy as primary intervention) are 
two issues that show how ethically complex EI can be in such a population 
25,26
. 
 
 
Fidelity to EI programmes 
 
An EI programme will only deliver the expected results if it is actually implemented and 
conducted as originally designed. To ensure this, EI programmes prioritize what are called 
fidelity measures: instruments to assess how strictly the delivered program adheres to the 
proposed model. Adherence to the protocol or programme originally developed means more 
than only including features that are critical to achieving the intended outcomes; it should also 
exclude those that would interfere 
27
.  
 
Fidelity measures are supported by research evidence showing that best results are actually 
achieved with the highest levels of fidelity to models 
28
.  
 
In Australia, researchers identified core components from the Early Psychosis Prevention and 
Intervention Centre (EPPIC), which is among the first EI programmes ever implemented, and 
are using them to form a fidelity measure instrument 
29
. This instrument will be applied 
throughout the country, as the EPPIC model expands.  
 
To ensure best and sustained effect of EI programmes, fidelity measures are not restricted to 
therapeutic interventions. Essential elements in the Australian model include aspects such as 
community awareness and ease of access to service – without which patient enrolment would 
risk being compromised – and continued staff development and training; clinical parameters 
include case management, medical and psychological treatments, and functional recovery, 
among others. 
 
The ambitious Recovery After an Initial Schizophrenia Episode: Early Treatment Program 
(RAISE-ETP), launched in the United States by the National Institute of Mental Health (NIMH), 
had fidelity measures incorporated in its design from its inception. Fidelity measures in RAISE-
ETP include demanding parameters such as “time to first self-reported meeting with a person 
who helped you get a job in the community or further your education” and “Were you asked to 
record your symptoms and side effects before you met with your psychiatrist or nurse 
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practitioner?” Such precisely formulated measures are also intended to ensure another key 
request from the NIMH: that the program would be capable of being delivered in US settings 
utilizing current funding mechanisms 
30
. 
 
Utility of feasibility measures exceeds ensuring adherence to the proposed EI model and 
enabling its replication. Since best outcomes are achieved with the highest levels of adherence 
to models, they can be used as proxy markers of success, and this is particularly useful in 
programmes aimed at psychosocial and social outcomes, because these typically take a long 
time to demonstrate effect 
27
.  
 
Considerable effort is dedicated to the development of fidelity measures. Instruments are 
aimed at assessing not only general programme parameters, but also adherence at staff team 
level and even at individual staff member’s level. Some instruments are formed as a scale, 
which yields a total score that can be translated into a quantified level of fidelity, such as the 
OPUS fidelity-scale, from Denmark, and the Calgary Fidelity Scale for First Episode Psychosis 
Services, from Canada 
31
. 
 
 
Dissemination of EI services  
 
Convincing evidence of effectiveness and methods to ensure fidelity has contributed to the 
dissemination of EI programmes throughout the world. 
 
Several convergent lines of evidence and theoretical models promoted stakeholders’ 
synergistic efforts. Ideas of kindling and neural networks were valued by biological 
psychiatrists; clinical psychologists were interested in theories that trauma might be at the root 
of psychotic phenomena and that the experience of positive psychotic phenomena is in itself 
traumatizing; social workers and social scientists were attracted by the model that links longer 
duration of untreated psychosis to loss of social capital, opportunities and friends, 
disintegration of families, and social breakdown. Furthermore, concepts of age-appropriate 
services, recovery and – last but not least – health economics also converged. These 
stakeholders were agreeing with patients, families, advocacy groups, carers, and policy 
makers about the importance of early intervention. 
 
In spite of persuasive high-quality evidence, there are still threats to wider dissemination and 
even continuity of EI programmes. For example, in Japan there are several leading centres of 
EI research and practice, but most of them are driven by university departments 
32
, and this is 
the reality in most of the world, including most of Europe.  
 
To understand why effective and well-accepted services with a favourable cost-benefit balance 
are not yet widely implemented throughout the world, it is necessary to acknowledge that EI 
shares some of the same obstacles that mental health care in general faces. These include 
low prioritization, stigmatisation, and structural problems, within a context of constrained health 
system budgets, to name a few. 
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Expenditure on mental disorders is one of the highest areas of health expenditure, 
representing between 5% and 18% of all health expenditures for a selection of countries 
33
. At 
first sight these figures might seem adequate, but when the burden of ill mental health care on 
society is taken into account, the proportion of public expenditure to healthcare is often small. 
For instance, mental illness is responsible for 23% of England’s total burden of disease, but 
receives 13% of the National Health System health expenditures 
33
. Moreover these costs are 
highly conservative, as the exclude the impacts of avoidable somatic comorbidities. 
34
 
 
The problem is exacerbated by the effect of stigmatisation of mental illness. Suppressing 
stigmatisation requires additional specific resources and well-orchestrated initiatives. For 
instance, about 15 years ago, the general public in Hong Kong could not differentiate between 
symptoms of psychosis and symptoms of stress. Efforts to raise awareness about psychosis 
and facilitate EI led to a series of comprehensive, long-term and focused campaigns that 
changed the general perception about psychosis; this included changing the Chinese term for 
psychosis from “serious mental illness” to something that means “thought and perception 
dysregulation” 35.  
 
Insufficient recognition of specific needs of patients with early psychosis can be detected even 
where it is less expected. A survey of 160 psychiatrists in Tokyo suggested that the concept of 
at-risk mental state and prodromal state might not be widely recognized among Japanese 
psychiatrists 
32
. In line with this, criticism has been made of university training curricula, which 
rarely include the topic of prevention and early detection of mental disorders 
36
. 
 
Structural problems can also represent a big obstacle, as is the case of a mental healthcare 
system largely based on institutionalised patients. In Japan, for example, where 
institutionalisation and social isolation of patients with severe mental illness is common, the 
task of deinstitutionalisation is considered a priority 
32
. But deinstitutionalisation might prove 
challenging in a country with a high reliance on hospital-based psychiatry, and where 90% of 
psychiatric beds are operated by the private sector 
37
. Experience from countries where 
deinstitutionalisation and implementation of EI services started earlier, as in Denmark, might 
thus by usefully shared with countries at earlier stages in the deinstitutionalisation process 
33
. 
 
The successful case of dissemination of EI in Australia illustrates how early and isolated 
programmes, with no consistent policy or funding support and led by champions in local areas, 
can be transformed and expanded by lobbying, national mobilisation, destigmatisation 
campaigns, and good integration with other sectors. These efforts resulted in the creation of 
cabinet-level political administration for mental issues and enormous popular support for 
mental health issues 
38
.  
 
In developing countries, challenges to the dissemination of EI are even greater. A recent study 
identified seven EI services in Latin America, four of which were based inside tertiary hospitals 
or universities; the authors point that lack of EI services in rural areas or in cities without 
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universities of tertiary hospitals can be problematic, and collaboration between clinical and 
research teams is warranted in order expand EI services in the region 
39
.  
 
Even in countries where EI services are relatively well established, such as the UK, there are 
inequalities on access and referral to these services, as reflected by different pathways to care 
by different social-economic or ethnic populations 
40
.  
 
The path to widespread dissemination and implementation of EI might vary, but always 
depends on support from health authorities or politicians. In Denmark, robust evidence from 
the OPUS trial convinced politicians to support the dissemination of EI programmes, and 
special grants were created. Between 1998 and 2013 the country had a tenfold increase in the 
numbers of EI teams, though a further increase in 50% is still needed to meet the demand of 
incident cases 
41
. 
 
Finally, dissemination of EI programmes means not only proliferation of EI service locations or 
teams, but – just as important – continued high level of fidelity. This means not only adherence 
to the designed model, procedures, and staff training, but also continued funding of all these 
components.  
 
Discussion  
 
As the figures from England and the NHS exemplified, there is a known and unquestionable 
funding gap for mental health services. Even while OECD health budgets are being squeezed, 
there is a strong case for ensuring adequate mental health service provision, and this may well 
mean increased funding. Efforts also need to be made to make sure that new, and existing 
resources, are spent as effectively as possible, delivering the best care and the best outcomes 
33
. 
 
There is clearly an economic case for investment in EI. For example, there is a high probability 
of OPUS being cost-effective, with lower costs and better outcomes, compared to standard 
treatment; and this analysis does not look into impact on employment or into issues such as 
education and housing needs 
42
. In England, results show that EI costs less than standard 
care; services for early detection of high risk states cost more in the first 12 months, but by 24 
months are already saving money, and cost-savings increase at 36 months, particularly when 
benefits beyond the health care system are considered 
15,43
.  
 
Therefore, arguments for more funding should not be restricted to the positive impact on the 
mental healthcare system, because this system alone does not benefit from all parts of EI 
programmes. It is necessary to identify all beneficiaries of the favourable outcomes of EI 
programmes and make them aware that they are in fact stakeholders. Positive impacts of EI 
programmes can be measured in terms of a reduction in excess unemployment and lost life 
opportunities, more people paying tax as a result of completing education and being in 
employment and potentially a reduction in the costs of managing avoidable physical health 
problems, to name a few. 
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Taken together, the effect on these areas represents a huge economic argument. In Japan, a 
conservative estimate that does not include impacts of poor physical health shows that 72% of 
costs of schizophrenia fall outside of the health system 
44
. 
 
Given the multi-sectorial nature of mental health issues, several ministries at national, regional 
and local level – including justice, labour, social affairs, housing and education – could be 
involved in governance for mental health, a healthcare sector that has moved away from the 
organisational and financial simplicity of a single setting for care delivery. Administrative 
responsibility for different areas of health and social care is often separate, with different 
governance and financial structures inhibiting meaningful integration of policies and 
approaches across fields. 
 
EI is associated with significant net savings per person during a three-year period from 
improved employment and education outcomes 
45
. The challenge here is that the health 
ministry does not benefit from these outcomes, it is the ministry of labour or of education. 
Different ways of incentivising sectors to work together to improve service delivery may be 
considered; these can include shared budgets for specific services or budgetary transfers by 
the ministry of finance between sectors. Lessons can be drawn from examples of effective 
approaches to partnership working across sectors in other areas of health policy 
46
.  
 
Research results about the impact of EI services on these different stakeholders are starting to 
accumulate, but more information is needed. Increased integration with other sectors might be 
part of the solution.  
 
Innovative approaches are needed to assist healthcare planners and help integrate 
stakeholders. In England and Wales, a state-of-the-art free online tool generates accurate and 
reliable data on the expected incidence of new, clinically-relevant cases per year of psychotic 
disorder, thus allowing more effective planning with an appropriate allocation of resources 
47
. 
Ultimately, the widespread implementation of optimised EI programmes is a matter of 
information transformed into action. Good and complete information – for instance on costs 
and outcomes – needs to be made available to governments and policy makers. Politicians 
and civil servants are obvious targets, but it is also about raising awareness more generally of 
the potential return on investment in services for people with psychosis.  
 
To achieve this, professionals involved in EI should continue building and strengthening 
domestic and international networks. But, above all, researchers and practitioners have to 
keep pumping out evidence, and make a convincing story. Researchers have to answer the 
questions that clinicians and payers actually want to be answered - making the case by 
matching what we know to what payers believe can be achieved. 
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